董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Douglas A. Berthiaume -- 董事长 68 30.39万(USD) -- 2017-03-29
Christopher J. O' Connell 董事,总裁兼首席执行官 50 763.10万(USD) -- 2017-03-29
JoAnn A. Reed 董事 61 30.19万(USD) -- 2017-03-29
Christopher A. Kuebler 董事 63 28.99万(USD) -- 2017-03-29
Laurie H. Glimcher 董事 65 28.54万(USD) -- 2017-03-29
Thomas P. Salice 董事 57 33.16万(USD) -- 2017-03-29
Michael J. Berendt 董事 68 29.69万(USD) -- 2017-03-29
Edward Conard 董事 60 29.44万(USD) -- 2017-03-29
William J. Miller 董事 71 31.19万(USD) -- 2017-03-29

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Michael C. Harrington -- 高级副总裁,全球市场 -- 259.94万(USD) -- 2017-03-29
Terrance P. Kelly 高级副总裁兼总裁,TA仪器 -- -- -- 2017-03-29
Rohit Khanna -- 高级副总裁,应用技术 -- 224.69万(USD) -- 2017-03-29
Ian S. King 高级副总裁,仪器技术 -- 228.21万(USD) -- 2017-03-29
David A. Terricciano 高级副总裁,全球运营 -- -- -- 2017-03-29
Christopher J. O' Connell 董事,总裁兼首席执行官 50 763.10万(USD) -- 2017-03-29
Sherry L. Buck 高级副总裁兼首席财务官 -- -- -- 2017-03-29
Mark T. Beaudouin 高级副总裁,总法律顾问兼秘书 -- 210.91万(USD) -- 2017-03-29
Elizabeth B. Rae 高级副总裁,全球人力资源 -- 158.41万(USD) -- 2017-03-29
Sherry L. Buck -- 高级副总裁兼首席财务官 -- -- -- 2017-03-29

董事简历

中英对照 |  中文 |  英文
Douglas A. Berthiaume

Douglas A. Berthiaume,1996年2月开始担任董事会主席;1994年8月起担任CEO兼董事。1994年8月至2002年1月,他担任公司总裁。2003年3月,他他再一次任公司总裁。1990至1994年,他密理博Waters Chromatography 分部总裁。他现在是儿童医院董事会主席和儿童医院医疗中心和马萨诸塞大学阿默斯特基金会董事。2013年8月,他提出希望在2015年以CEO名义退休。


Douglas A. Berthiaume has served as Chairman of the Board since February 1996 and served as President, Chief Executive Officer and a Director of the Company from August 1994 except from January 2002 to March 2003 during which time he did not serve as President until September 2015. From 1990 to 1994 Mr. Berthiaume served as President of the Waters Chromatography Division of Millipore Corporation, the predecessor business of the Company, which was purchased in 1994. Mr. Berthiaume is the Chairman of the Children’s Hospital Trust Board, and a trustee of the Children’s Hospital Medical Center and The University of Massachusetts Amherst Foundation.
Douglas A. Berthiaume,1996年2月开始担任董事会主席;1994年8月起担任CEO兼董事。1994年8月至2002年1月,他担任公司总裁。2003年3月,他他再一次任公司总裁。1990至1994年,他密理博Waters Chromatography 分部总裁。他现在是儿童医院董事会主席和儿童医院医疗中心和马萨诸塞大学阿默斯特基金会董事。2013年8月,他提出希望在2015年以CEO名义退休。
Douglas A. Berthiaume has served as Chairman of the Board since February 1996 and served as President, Chief Executive Officer and a Director of the Company from August 1994 except from January 2002 to March 2003 during which time he did not serve as President until September 2015. From 1990 to 1994 Mr. Berthiaume served as President of the Waters Chromatography Division of Millipore Corporation, the predecessor business of the Company, which was purchased in 1994. Mr. Berthiaume is the Chairman of the Children’s Hospital Trust Board, and a trustee of the Children’s Hospital Medical Center and The University of Massachusetts Amherst Foundation.
Christopher J. O' Connell

Christopher J. O' Connell,他曾一直担任公司的董事(2015年9月以来)。他于2015年9月被任命为公司的总裁兼首席执行官。他曾担任Medtronic plc的恢复性治疗集团的执行副总裁兼总裁(2009年8月至2015年8月)。从1994年到2009年8月,他曾担任Medtronic plc的多种职务,如下:Medtronic Diabetes公司的高级副总裁兼总裁、Medtronic Physio-Control公司的总裁、心脏节律管理业务的销售和营销副总裁、病人管理业务的副总裁兼总经理、公司战略副总裁、投资者关系董事兼公司开发助理。


Christopher J. O' Connell has served as a Director of the Company since September 2015 when he assumed the position of President and Chief Executive Officer of the Company. Mr. O’Connell served as Executive Vice President and President of the Restorative Therapies Group of Medtronic plc from August 2009 to August 2015. From 1994 to August 2009 Mr. O’Connell served in the following positions at Medtronic plc: Senior Vice President and President of Medtronic Diabetes, President of Medtronic Physio-Control, Vice President of Sales and Marketing for the Cardiac Rhythm Management business, Vice President/General Manager of the Patient Management business, Vice President of Corporate Strategy, Director of Investor Relations and Corporate Development Associate.
Christopher J. O' Connell,他曾一直担任公司的董事(2015年9月以来)。他于2015年9月被任命为公司的总裁兼首席执行官。他曾担任Medtronic plc的恢复性治疗集团的执行副总裁兼总裁(2009年8月至2015年8月)。从1994年到2009年8月,他曾担任Medtronic plc的多种职务,如下:Medtronic Diabetes公司的高级副总裁兼总裁、Medtronic Physio-Control公司的总裁、心脏节律管理业务的销售和营销副总裁、病人管理业务的副总裁兼总经理、公司战略副总裁、投资者关系董事兼公司开发助理。
Christopher J. O' Connell has served as a Director of the Company since September 2015 when he assumed the position of President and Chief Executive Officer of the Company. Mr. O’Connell served as Executive Vice President and President of the Restorative Therapies Group of Medtronic plc from August 2009 to August 2015. From 1994 to August 2009 Mr. O’Connell served in the following positions at Medtronic plc: Senior Vice President and President of Medtronic Diabetes, President of Medtronic Physio-Control, Vice President of Sales and Marketing for the Cardiac Rhythm Management business, Vice President/General Manager of the Patient Management business, Vice President of Corporate Strategy, Director of Investor Relations and Corporate Development Associate.
JoAnn A. Reed

JoAnn A. Reed,自2007年5月担任董事,并于2007年11月担任审计委员会成员。目前,她担任医疗保健服务方面的咨询顾问。她曾在Medco Health Solutions公司担任高级副总裁,负责金融事务,并担任财务总监,直至2008年3月卸任。该公司是一家药品福利管理企业。在于1988年进入Medco公司后,她曾担任与金融和会计有关的多个职务,包括于1992年担任高级副总裁,负责金融事务,并于1996年担任财务总监。在进入Medco公司前,她曾在Aetna/American Re-Insurance Co., CBS公司、Standard and Poor公司和Unisys/Timeplex公司担任多个金融方面的职务。目前,她在Mallinckrodt公司和Waters 公司担任董事。她还在印第安纳的圣母圣玛丽学院(St. Mary’s College of Notre Dame)担任理事。


JoAnn A. Reed has served as a Director of the Company since May 2006. Ms. Reed has been a health care services consultant since 2010. From April 2008 to April 2009 she was an advisor to the Chief Executive Officer of Medco Health Solutions, Inc. From 2002 to March 2008 Ms. Reed served as Senior Vice President, Finance and Chief Financial Officer of Medco Health Solutions, Inc. From 1992 to 2002 she served as Senior Vice President, Finance of Medco Health Solutions, Inc. She joined Medco Containment Services, Inc. in 1988.
JoAnn A. Reed,自2007年5月担任董事,并于2007年11月担任审计委员会成员。目前,她担任医疗保健服务方面的咨询顾问。她曾在Medco Health Solutions公司担任高级副总裁,负责金融事务,并担任财务总监,直至2008年3月卸任。该公司是一家药品福利管理企业。在于1988年进入Medco公司后,她曾担任与金融和会计有关的多个职务,包括于1992年担任高级副总裁,负责金融事务,并于1996年担任财务总监。在进入Medco公司前,她曾在Aetna/American Re-Insurance Co., CBS公司、Standard and Poor公司和Unisys/Timeplex公司担任多个金融方面的职务。目前,她在Mallinckrodt公司和Waters 公司担任董事。她还在印第安纳的圣母圣玛丽学院(St. Mary’s College of Notre Dame)担任理事。
JoAnn A. Reed has served as a Director of the Company since May 2006. Ms. Reed has been a health care services consultant since 2010. From April 2008 to April 2009 she was an advisor to the Chief Executive Officer of Medco Health Solutions, Inc. From 2002 to March 2008 Ms. Reed served as Senior Vice President, Finance and Chief Financial Officer of Medco Health Solutions, Inc. From 1992 to 2002 she served as Senior Vice President, Finance of Medco Health Solutions, Inc. She joined Medco Containment Services, Inc. in 1988.
Christopher A. Kuebler

Christopher A. Kuebler,2001年12月他担任公司董事。他现在也在Waters公司董事会任职,Waters是一家分析技术服务公司。1997年1月至2005年12月, 他担任Covance 公司董事会主席,Covance是一家药物开发服务公司。1994年11月至2004年12月,他担任CEO。1993年3月至1994年11月担任雅培公司欧洲运营副总裁,雅培是一家多样化健康保健公司。1986年1月至1993年3月, 他在雅培制药部担任过很多职位,曾担任部门副总裁,在这之前他负责欧洲市场营销。他也曾在Squibb公司和Monsanto医疗保健公司任职。他拥有加州大学生物科学学士学位。


Christopher A. Kuebler has served as a Director of the Company since May 2006. He has been an independent director and investor since 2005. He served as Chairman and Chief Executive Officer of Covance Inc. and its predecessor companies from November 1994 to December 2004 and as Chairman during 2005. Prior to joining Covance, Inc., Mr. Kuebler spent nearly 20 years in the pharmaceutical industry at Abbott Laboratories, Squibb, Inc. and the Monsanto Company.
Christopher A. Kuebler,2001年12月他担任公司董事。他现在也在Waters公司董事会任职,Waters是一家分析技术服务公司。1997年1月至2005年12月, 他担任Covance 公司董事会主席,Covance是一家药物开发服务公司。1994年11月至2004年12月,他担任CEO。1993年3月至1994年11月担任雅培公司欧洲运营副总裁,雅培是一家多样化健康保健公司。1986年1月至1993年3月, 他在雅培制药部担任过很多职位,曾担任部门副总裁,在这之前他负责欧洲市场营销。他也曾在Squibb公司和Monsanto医疗保健公司任职。他拥有加州大学生物科学学士学位。
Christopher A. Kuebler has served as a Director of the Company since May 2006. He has been an independent director and investor since 2005. He served as Chairman and Chief Executive Officer of Covance Inc. and its predecessor companies from November 1994 to December 2004 and as Chairman during 2005. Prior to joining Covance, Inc., Mr. Kuebler spent nearly 20 years in the pharmaceutical industry at Abbott Laboratories, Squibb, Inc. and the Monsanto Company.
Laurie H. Glimcher

Laurie H. Glimcher自1998年1月起担任公司董事。Glimcher是Weill Cornell Medical College的Stephen and Suzanne Weiss院长,以及Cornell University医疗事务教务长。Glimcher从1991年到2011年担任Harvard School of Public Health免疫学Irene Heinz Given教授;以及Harvard Medical School医学教授。Glimcher是Bristol-Myers Squibb Company董事。她是 American Academy of Arts and Sciences研究员;National Academy of Sciences成员以及Institutes of Medicine of the National Academy of Sciences成员。


Laurie H. Glimcher has served as a Director of the Company since January 1998. Dr. Glimcher is the President and Chief Executive Officer of the Dana-Farber Cancer Institute, the Principal Investigator and Director of the Dana-Farber/Harvard Cancer Center and the Richard and Susan Smith Professor of Medicine, Harvard Medical School. From January 2012 to June 2016 Dr. Glimcher served as the Stephen and Suzanne Weiss Dean of the Weill Cornell Medical College and Provost for Medical Affairs of Cornell University. From 1991 through 2011 Dr. Glimcher served as the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health and Professor of Medicine at Harvard Medical School.
Laurie H. Glimcher自1998年1月起担任公司董事。Glimcher是Weill Cornell Medical College的Stephen and Suzanne Weiss院长,以及Cornell University医疗事务教务长。Glimcher从1991年到2011年担任Harvard School of Public Health免疫学Irene Heinz Given教授;以及Harvard Medical School医学教授。Glimcher是Bristol-Myers Squibb Company董事。她是 American Academy of Arts and Sciences研究员;National Academy of Sciences成员以及Institutes of Medicine of the National Academy of Sciences成员。
Laurie H. Glimcher has served as a Director of the Company since January 1998. Dr. Glimcher is the President and Chief Executive Officer of the Dana-Farber Cancer Institute, the Principal Investigator and Director of the Dana-Farber/Harvard Cancer Center and the Richard and Susan Smith Professor of Medicine, Harvard Medical School. From January 2012 to June 2016 Dr. Glimcher served as the Stephen and Suzanne Weiss Dean of the Weill Cornell Medical College and Provost for Medical Affairs of Cornell University. From 1991 through 2011 Dr. Glimcher served as the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health and Professor of Medicine at Harvard Medical School.
Thomas P. Salice

Thomas P. Salice,从1996年10月开始担任董事,是审计委员会成员和薪酬委员会主席。她是SFW 资本合作公司共同创建者和主管,SFW 是一家私人股权公司。他从2005年1月开始SFW 资本合作公司常务董事。1989年6月至2004年12月,他在AEA 投资公司担任过各种职位,包括常务董事、总裁、CEO和副董事长。他拥有哈佛大学工商管理硕士学位。他也是Waters 公司董事和私人企业Agknowledge控股公司、工业动力控股有限公司、MD Buyline公司和斯派克公司董事。


Thomas P. Salice has served as a Director of the Company since July 1994. Mr. Salice is a co-founder and managing member of SFW Capital Partners, LLC, a private equity firm. He has served as a Managing Member of SFW Capital Partners, LLC since January 2005. From June 1989 to December 2004 Mr. Salice served in a variety of capacities with AEA Investors, Inc., including Managing Director, President and Chief Executive Officer and Vice-Chairman. Mr. Salice is Director of several privately held companies: Essen Bioscience, Inc., Filtec, Gerson Lehrman Group, Inc., and Spectro Scientific, Inc.
Thomas P. Salice,从1996年10月开始担任董事,是审计委员会成员和薪酬委员会主席。她是SFW 资本合作公司共同创建者和主管,SFW 是一家私人股权公司。他从2005年1月开始SFW 资本合作公司常务董事。1989年6月至2004年12月,他在AEA 投资公司担任过各种职位,包括常务董事、总裁、CEO和副董事长。他拥有哈佛大学工商管理硕士学位。他也是Waters 公司董事和私人企业Agknowledge控股公司、工业动力控股有限公司、MD Buyline公司和斯派克公司董事。
Thomas P. Salice has served as a Director of the Company since July 1994. Mr. Salice is a co-founder and managing member of SFW Capital Partners, LLC, a private equity firm. He has served as a Managing Member of SFW Capital Partners, LLC since January 2005. From June 1989 to December 2004 Mr. Salice served in a variety of capacities with AEA Investors, Inc., including Managing Director, President and Chief Executive Officer and Vice-Chairman. Mr. Salice is Director of several privately held companies: Essen Bioscience, Inc., Filtec, Gerson Lehrman Group, Inc., and Spectro Scientific, Inc.
Michael J. Berendt

Michael J. Berendt,1998年3月开始担任董事,是独立董事和投资人。2006年3月至2011年7月,他担任Aegera 疗法公司总裁兼CEO。2004年8月至2005年12月,他担任企业技术研究常务董事。2000年11月至2004年8月担任AEA投资公司常务董事。他在医药行业从事了18年,从1982年-2000年,担任各种高级管理职位,包括拜耳公司医药研究部门高级副总裁、辉瑞公司要去研发主管。他也曾担任Onyx制药公司、利亚德基因公司、催化剂生物科学和北极星神经学董事。


Michael J. Berendt has served as a Director of the Company since March 1998. Since December 2016 Dr. Berendt has been a life sciences industry consultant. From November 2013 to November 2016 Dr. Berendt was the Chief Executive Officer and Chief Scientist of Telesta Therapeutics. From July 2011 to November 2013 Dr. Berendt was a life sciences industry consultant. From March 2006 to July 2011 Dr. Berendt served as the President and Chief Executive Officer of Aegera Therapeutics Inc. From August 2004 to December 2005 Dr. Berendt served as Managing Director of Research Corporation Technologies, Inc. From November 2000 to August 2004 Dr. Berendt served as Managing Director of AEA Investors LP. Dr. Berendt also worked for 18 years, from 1982 to 2000 in the pharmaceutical industry where he served in a number of senior management positions including Senior Vice President of Research for the Pharmaceutical Division of Bayer Corporation, and a Group Director of Drug Discovery at Pfizer, Inc.
Michael J. Berendt,1998年3月开始担任董事,是独立董事和投资人。2006年3月至2011年7月,他担任Aegera 疗法公司总裁兼CEO。2004年8月至2005年12月,他担任企业技术研究常务董事。2000年11月至2004年8月担任AEA投资公司常务董事。他在医药行业从事了18年,从1982年-2000年,担任各种高级管理职位,包括拜耳公司医药研究部门高级副总裁、辉瑞公司要去研发主管。他也曾担任Onyx制药公司、利亚德基因公司、催化剂生物科学和北极星神经学董事。
Michael J. Berendt has served as a Director of the Company since March 1998. Since December 2016 Dr. Berendt has been a life sciences industry consultant. From November 2013 to November 2016 Dr. Berendt was the Chief Executive Officer and Chief Scientist of Telesta Therapeutics. From July 2011 to November 2013 Dr. Berendt was a life sciences industry consultant. From March 2006 to July 2011 Dr. Berendt served as the President and Chief Executive Officer of Aegera Therapeutics Inc. From August 2004 to December 2005 Dr. Berendt served as Managing Director of Research Corporation Technologies, Inc. From November 2000 to August 2004 Dr. Berendt served as Managing Director of AEA Investors LP. Dr. Berendt also worked for 18 years, from 1982 to 2000 in the pharmaceutical industry where he served in a number of senior management positions including Senior Vice President of Research for the Pharmaceutical Division of Bayer Corporation, and a Group Director of Drug Discovery at Pfizer, Inc.
Edward Conard

Edward Conard,从1994年8月开始担任公司董事。他是独立董事和投资人。1993年3月至2007年12月,他担任贝恩公司常务董事。他之前是佩雷拉集团董事,是一家投资银行公司,专注于并购。他也曾是贝恩公司副总裁,负责各区运营。他还是 尤尼索斯国际公司董事。


Edward Conard has served as a Director of the Company since August 1994. He has been an independent director and investor since January 2008 . Mr. Conard was a Managing Director of Bain Capital, LLC from March 1993 to December 2007. Mr. Conard was previously a Director of Wasserstein Perella & Co., Inc., an investment banking firm that specializes in mergers and acquisitions, and a Vice President of Bain & Company heading up the firm’s operations practice area.
Edward Conard,从1994年8月开始担任公司董事。他是独立董事和投资人。1993年3月至2007年12月,他担任贝恩公司常务董事。他之前是佩雷拉集团董事,是一家投资银行公司,专注于并购。他也曾是贝恩公司副总裁,负责各区运营。他还是 尤尼索斯国际公司董事。
Edward Conard has served as a Director of the Company since August 1994. He has been an independent director and investor since January 2008 . Mr. Conard was a Managing Director of Bain Capital, LLC from March 1993 to December 2007. Mr. Conard was previously a Director of Wasserstein Perella & Co., Inc., an investment banking firm that specializes in mergers and acquisitions, and a Vice President of Bain & Company heading up the firm’s operations practice area.
William J. Miller

William J. Miller,自2007年1月起担任董事;从2009年7月到2010年1月担任联合董事长;自2010年1月起担任公司独立董事长。 担任该职位之前,曾于2009年12月起开始担任代理总裁兼首席执行官。从1999年11月起,他在多个科技公司担任独立总裁。从1996年4月到1999年11月,他担任狂热公司(多媒体公司数据产品供应商)董事长兼首席执行官;1996年9月到1999年1月开始担任该公司总裁。 在此之前,他担任量子公司(数据存储制造商)首席执行官和董事长。他在数据控制公司(一家计算机与数据服务公司)担任多个数据存储、信息服务以及金融服务业务领域担任多个职位。他也是英伟达公司、沃特世公司,、Digimarc公司和Quantance公司董事。在过去五年中,他还担任陆路存储有限公司和优派公司董事。他持有明尼苏达大学语音通信学士学位以及法律博士学位。


William J. Miller has served as a Director of the Company since January 1998. Mr. Miller has been an independent director and investor since 1999. From April 1996 to November 1999 Mr. Miller served as Chief Executive Officer and Chairman of the Board of Directors of Avid Corporation, where from September 1996 to January 1999 he served as President. From March 1992 to September 1995 Mr. Miller served as Chief Executive Officer of Quantum Corporation. From May 1992 to September 1995 Mr. Miller served as a member of the Board of Directors of Quantum Corporation and from September 1993 to August 1995 he served as Chairman of its Board of Directors. From 1981 to March 1992 he served in various positions at Control Data Corporation, most recently as Executive Vice President and President, Information Services.
William J. Miller,自2007年1月起担任董事;从2009年7月到2010年1月担任联合董事长;自2010年1月起担任公司独立董事长。 担任该职位之前,曾于2009年12月起开始担任代理总裁兼首席执行官。从1999年11月起,他在多个科技公司担任独立总裁。从1996年4月到1999年11月,他担任狂热公司(多媒体公司数据产品供应商)董事长兼首席执行官;1996年9月到1999年1月开始担任该公司总裁。 在此之前,他担任量子公司(数据存储制造商)首席执行官和董事长。他在数据控制公司(一家计算机与数据服务公司)担任多个数据存储、信息服务以及金融服务业务领域担任多个职位。他也是英伟达公司、沃特世公司,、Digimarc公司和Quantance公司董事。在过去五年中,他还担任陆路存储有限公司和优派公司董事。他持有明尼苏达大学语音通信学士学位以及法律博士学位。
William J. Miller has served as a Director of the Company since January 1998. Mr. Miller has been an independent director and investor since 1999. From April 1996 to November 1999 Mr. Miller served as Chief Executive Officer and Chairman of the Board of Directors of Avid Corporation, where from September 1996 to January 1999 he served as President. From March 1992 to September 1995 Mr. Miller served as Chief Executive Officer of Quantum Corporation. From May 1992 to September 1995 Mr. Miller served as a member of the Board of Directors of Quantum Corporation and from September 1993 to August 1995 he served as Chairman of its Board of Directors. From 1981 to March 1992 he served in various positions at Control Data Corporation, most recently as Executive Vice President and President, Information Services.

高管简历

中英对照 |  中文 |  英文
Michael C. Harrington

Michael C. Harrington2016年2月被任命为全球市场的高级副总裁。1987年,Harrington博士在Waters担任多个高级职位,包括欧洲和亚太地区业务的副总裁,美国市场销售业务的高级总监,美国化学销售董事和Phase Separations的总经理。加入Waters之前,Harrington博士曾在Celsis, Inc.担任高级销售职位。


Michael C. Harrington was appointed Senior Vice President, Global Markets in February 2016. Dr. Harrington joined Waters Corporation in 1987 and has held several senior positions with Waters Corporation, including Vice President, Europe and Asia Pacific Operations, Senior Director of US Sales Operations, Director of US Chemistry Sales and General Manager of Phase Separations. Prior to joining Waters Corporation, Dr. Harrington held senior sales positions at Celsis, Inc.
Michael C. Harrington2016年2月被任命为全球市场的高级副总裁。1987年,Harrington博士在Waters担任多个高级职位,包括欧洲和亚太地区业务的副总裁,美国市场销售业务的高级总监,美国化学销售董事和Phase Separations的总经理。加入Waters之前,Harrington博士曾在Celsis, Inc.担任高级销售职位。
Michael C. Harrington was appointed Senior Vice President, Global Markets in February 2016. Dr. Harrington joined Waters Corporation in 1987 and has held several senior positions with Waters Corporation, including Vice President, Europe and Asia Pacific Operations, Senior Director of US Sales Operations, Director of US Chemistry Sales and General Manager of Phase Separations. Prior to joining Waters Corporation, Dr. Harrington held senior sales positions at Celsis, Inc.
Terrance P. Kelly

Terrance P. Kelly2016年2月被任命为TA Instruments的高级副总裁兼总裁。自2005年2月起,Kelly 先生担任TA instruments的总裁。1985年,Kelly先生在ICI 金融及会计开始其职业生涯。1988年他加入DuPont。他担任过DuPont(后来 TA Instruments)的各种销售和市场营销职位。当TAInstruments被收购时,1996年Kelly先生加入Waters。


Terrance P. Kelly was appointed Senior Vice President and President, TA Instruments in February 2016. Mr. Kelly has served as President, TA instruments since February 2005. Mr. Kelly started his career in finance and accounting at ICI in 1985. He joined DuPont in 1988. He held various sales and marketing positions with DuPont, and later TA Instruments. Mr. Kelly joined Waters Corporation in 1996 when TA Instruments was acquired.
Terrance P. Kelly2016年2月被任命为TA Instruments的高级副总裁兼总裁。自2005年2月起,Kelly 先生担任TA instruments的总裁。1985年,Kelly先生在ICI 金融及会计开始其职业生涯。1988年他加入DuPont。他担任过DuPont(后来 TA Instruments)的各种销售和市场营销职位。当TAInstruments被收购时,1996年Kelly先生加入Waters。
Terrance P. Kelly was appointed Senior Vice President and President, TA Instruments in February 2016. Mr. Kelly has served as President, TA instruments since February 2005. Mr. Kelly started his career in finance and accounting at ICI in 1985. He joined DuPont in 1988. He held various sales and marketing positions with DuPont, and later TA Instruments. Mr. Kelly joined Waters Corporation in 1996 when TA Instruments was acquired.
Rohit Khanna

Rohit Khanna 2016年2月被任命为应用技术的高级副总裁。自2002年以来,Khanna博士曾担任全球营销和信息的副总裁;还在Waters担任多个高级职位,包括客户保证的副总裁和数据产品副总裁。1986年当Dynamic Solutions被收购,Khanna博士加入Waters。Dynamic Solutions是Khanna博士共同创立和管理的一家公司。


Rohit Khanna was appointed Senior Vice President, Applied Technology in February 2016. Dr. Khanna previously served as Vice President, Worldwide Marketing and Informatics since 2002 and also held several senior positions with Waters Corporation, including Vice-President, Customer Assurance and Vice President, Data Products. Dr. Khanna joined Waters Corporation in 1986 when Dynamic Solutions, a company co-founded and managed by Dr. Khanna, was acquired.
Rohit Khanna 2016年2月被任命为应用技术的高级副总裁。自2002年以来,Khanna博士曾担任全球营销和信息的副总裁;还在Waters担任多个高级职位,包括客户保证的副总裁和数据产品副总裁。1986年当Dynamic Solutions被收购,Khanna博士加入Waters。Dynamic Solutions是Khanna博士共同创立和管理的一家公司。
Rohit Khanna was appointed Senior Vice President, Applied Technology in February 2016. Dr. Khanna previously served as Vice President, Worldwide Marketing and Informatics since 2002 and also held several senior positions with Waters Corporation, including Vice-President, Customer Assurance and Vice President, Data Products. Dr. Khanna joined Waters Corporation in 1986 when Dynamic Solutions, a company co-founded and managed by Dr. Khanna, was acquired.
Ian S. King

Ian S. King 2016年2月被任命为Instrument Technology的高级副总裁。金先生于1982年加入Waters,并曾担任Separations Technologies的副总裁;Consumable Division的副总统兼总经理,以及在Waters国际子公司担任各种科学及管理职位。在加入Waters之前,King先生曾在Edinburgh University担任一个研究科学家。


Ian S. King was appointed Senior Vice President, Instrument Technology in February 2016. Mr. King joined Waters in 1982 and previously served as Vice President, Separations Technologies and Vice President and General Manager of Consumable Division, as well as a variety of scientific and management positions in Waters Corporation’s international subsidiaries. Prior to joining Waters Corporation, Mr. King worked at Edinburgh University as a research scientist.
Ian S. King 2016年2月被任命为Instrument Technology的高级副总裁。金先生于1982年加入Waters,并曾担任Separations Technologies的副总裁;Consumable Division的副总统兼总经理,以及在Waters国际子公司担任各种科学及管理职位。在加入Waters之前,King先生曾在Edinburgh University担任一个研究科学家。
Ian S. King was appointed Senior Vice President, Instrument Technology in February 2016. Mr. King joined Waters in 1982 and previously served as Vice President, Separations Technologies and Vice President and General Manager of Consumable Division, as well as a variety of scientific and management positions in Waters Corporation’s international subsidiaries. Prior to joining Waters Corporation, Mr. King worked at Edinburgh University as a research scientist.
David A. Terricciano

David A. Terricciano 2016年2月被任命为全球运营的高级副总裁。自2001年8月起,Terricciano先生曾担任全球运营的副总裁。加盟Waters之前,他曾担任Perkin-Elmer Instruments的副总裁兼运营总经理。此前,他在Goodrich Aerospace、 Honeywell Aerospace 和Textron 公司担任过各种高管职位。


David A. Terricciano was appointed Senior Vice President, Global Operations in February 2016. Mr. Terricciano previously served as Vice President of Global Operations since August 2001. Prior to joining Waters Corporation, he worked as Vice President and General Manager of Operations for Perkin-Elmer Instruments. Previously, he held a variety of executive positions at Goodrich Aerospace, Honeywell Aerospace and Textron Corporation.
David A. Terricciano 2016年2月被任命为全球运营的高级副总裁。自2001年8月起,Terricciano先生曾担任全球运营的副总裁。加盟Waters之前,他曾担任Perkin-Elmer Instruments的副总裁兼运营总经理。此前,他在Goodrich Aerospace、 Honeywell Aerospace 和Textron 公司担任过各种高管职位。
David A. Terricciano was appointed Senior Vice President, Global Operations in February 2016. Mr. Terricciano previously served as Vice President of Global Operations since August 2001. Prior to joining Waters Corporation, he worked as Vice President and General Manager of Operations for Perkin-Elmer Instruments. Previously, he held a variety of executive positions at Goodrich Aerospace, Honeywell Aerospace and Textron Corporation.
Christopher J. O' Connell

Christopher J. O' Connell,他曾一直担任公司的董事(2015年9月以来)。他于2015年9月被任命为公司的总裁兼首席执行官。他曾担任Medtronic plc的恢复性治疗集团的执行副总裁兼总裁(2009年8月至2015年8月)。从1994年到2009年8月,他曾担任Medtronic plc的多种职务,如下:Medtronic Diabetes公司的高级副总裁兼总裁、Medtronic Physio-Control公司的总裁、心脏节律管理业务的销售和营销副总裁、病人管理业务的副总裁兼总经理、公司战略副总裁、投资者关系董事兼公司开发助理。


Christopher J. O' Connell has served as a Director of the Company since September 2015 when he assumed the position of President and Chief Executive Officer of the Company. Mr. O’Connell served as Executive Vice President and President of the Restorative Therapies Group of Medtronic plc from August 2009 to August 2015. From 1994 to August 2009 Mr. O’Connell served in the following positions at Medtronic plc: Senior Vice President and President of Medtronic Diabetes, President of Medtronic Physio-Control, Vice President of Sales and Marketing for the Cardiac Rhythm Management business, Vice President/General Manager of the Patient Management business, Vice President of Corporate Strategy, Director of Investor Relations and Corporate Development Associate.
Christopher J. O' Connell,他曾一直担任公司的董事(2015年9月以来)。他于2015年9月被任命为公司的总裁兼首席执行官。他曾担任Medtronic plc的恢复性治疗集团的执行副总裁兼总裁(2009年8月至2015年8月)。从1994年到2009年8月,他曾担任Medtronic plc的多种职务,如下:Medtronic Diabetes公司的高级副总裁兼总裁、Medtronic Physio-Control公司的总裁、心脏节律管理业务的销售和营销副总裁、病人管理业务的副总裁兼总经理、公司战略副总裁、投资者关系董事兼公司开发助理。
Christopher J. O' Connell has served as a Director of the Company since September 2015 when he assumed the position of President and Chief Executive Officer of the Company. Mr. O’Connell served as Executive Vice President and President of the Restorative Therapies Group of Medtronic plc from August 2009 to August 2015. From 1994 to August 2009 Mr. O’Connell served in the following positions at Medtronic plc: Senior Vice President and President of Medtronic Diabetes, President of Medtronic Physio-Control, Vice President of Sales and Marketing for the Cardiac Rhythm Management business, Vice President/General Manager of the Patient Management business, Vice President of Corporate Strategy, Director of Investor Relations and Corporate Development Associate.
Sherry L. Buck
暂无中文简介

Sherry L. Buck was appointed Senior Vice President and Chief Financial Officer in January 2017. Previously, Ms. Buck served as the Vice President, Chief Financial Officer of Libbey Inc. since August 2012. From 1993 to 2012 Ms. Buck held several positions at Whirlpool Corporation, including Vice President, Finance/Chief Financial Officer, Global Product and Enterprise Cost Leadership; Vice President, Finance - US; Vice President, Cost Leadership; Vice President, Finance - International; and Vice President, Business Performance Management.
暂无中文简介
Sherry L. Buck was appointed Senior Vice President and Chief Financial Officer in January 2017. Previously, Ms. Buck served as the Vice President, Chief Financial Officer of Libbey Inc. since August 2012. From 1993 to 2012 Ms. Buck held several positions at Whirlpool Corporation, including Vice President, Finance/Chief Financial Officer, Global Product and Enterprise Cost Leadership; Vice President, Finance - US; Vice President, Cost Leadership; Vice President, Finance - International; and Vice President, Business Performance Management.
Mark T. Beaudouin

Mark T. Beaudouin,从2003年4月起担任公司副总裁、法律总顾问兼秘书。加入 Waters之前,他于2000年1月至2003年4月期间担任PAREXEL国际公司高级副总裁、法律总顾问兼秘书,PAREXEL是一家生物制药服务公司。1985年5月至2000年1月,他担任公司几个高级法律管理职位,包括BC国际公司副总裁、法律总顾问兼秘书,BC国际是一家发展中生物科技公司;也担任 J. Baker公司第一高级副总裁、法律总顾问兼秘书,J. Baker是一家多样化零售公司;还任GenRad公司法律总顾问兼秘书,GenRad是一家高科技检测设备制造商。


Mark T. Beaudouin was appointed Senior Vice President, General Counsel and Secretary in February 2016 and was Vice President, General Counsel and Secretary of the Company since April 2003. Prior to joining Waters Corporation, he served as Senior Vice President, General Counsel and Secretary of PAREXEL International Corporation, a bio/pharmaceutical services company, from January 2000 to April 2003. Previously, from May 1985 to January 2000 Mr. Beaudouin served in several senior legal management positions, including Vice President, General Counsel and Secretary of BC International, Inc., a development stage biotechnology company, First Senior Vice President, General Counsel and Secretary of J. Baker, Inc., a diversified retail company, and General Counsel and Secretary of GenRad, Inc., a high technology test equipment manufacturer.
Mark T. Beaudouin,从2003年4月起担任公司副总裁、法律总顾问兼秘书。加入 Waters之前,他于2000年1月至2003年4月期间担任PAREXEL国际公司高级副总裁、法律总顾问兼秘书,PAREXEL是一家生物制药服务公司。1985年5月至2000年1月,他担任公司几个高级法律管理职位,包括BC国际公司副总裁、法律总顾问兼秘书,BC国际是一家发展中生物科技公司;也担任 J. Baker公司第一高级副总裁、法律总顾问兼秘书,J. Baker是一家多样化零售公司;还任GenRad公司法律总顾问兼秘书,GenRad是一家高科技检测设备制造商。
Mark T. Beaudouin was appointed Senior Vice President, General Counsel and Secretary in February 2016 and was Vice President, General Counsel and Secretary of the Company since April 2003. Prior to joining Waters Corporation, he served as Senior Vice President, General Counsel and Secretary of PAREXEL International Corporation, a bio/pharmaceutical services company, from January 2000 to April 2003. Previously, from May 1985 to January 2000 Mr. Beaudouin served in several senior legal management positions, including Vice President, General Counsel and Secretary of BC International, Inc., a development stage biotechnology company, First Senior Vice President, General Counsel and Secretary of J. Baker, Inc., a diversified retail company, and General Counsel and Secretary of GenRad, Inc., a high technology test equipment manufacturer.
Elizabeth B. Rae

Elizabeth B. Rae,2005年10月起担任人力资源副总裁。2002年1月开始任全球薪酬和福利委员会副总裁。她于1996年1月加入Waters,在担任零售、医疗保健和金融服务公司人力资源高级职位。


Elizabeth B. Rae was appointed Senior Vice President, Global Human Resources in February 2016 and was Vice President of Human Resources since October 2005 and Vice President of Worldwide Compensation and Benefits since January 2002. Ms. Rae joined Waters Corporation in January 1996 as Director of Worldwide Compensation. Prior to joining Waters Corporation, she held senior human resources positions in retail, healthcare and financial services companies.
Elizabeth B. Rae,2005年10月起担任人力资源副总裁。2002年1月开始任全球薪酬和福利委员会副总裁。她于1996年1月加入Waters,在担任零售、医疗保健和金融服务公司人力资源高级职位。
Elizabeth B. Rae was appointed Senior Vice President, Global Human Resources in February 2016 and was Vice President of Human Resources since October 2005 and Vice President of Worldwide Compensation and Benefits since January 2002. Ms. Rae joined Waters Corporation in January 1996 as Director of Worldwide Compensation. Prior to joining Waters Corporation, she held senior human resources positions in retail, healthcare and financial services companies.
Sherry L. Buck

Sherry L. Buck ,于2012年8月1日加入Libbey,担任副总裁以及财务总监。她从Whirlpool 公司 (NYSE: WHR)转到了Libbey公司,她是于1993年加入Whirlpool并自2010年10月以来最近担任全球产品和企业成本管理首席执行官的。在2009-2010年10月以来,她曾是财务副总裁(美国),以及在2007-2008年末,她曾担任成本管理副总裁。他先前在Whirlpool的职位包括财务副总裁(国际)以及企业绩效管理副总裁。


Sherry L. Buck joined Libbey as Vice President, Chief Financial Officer on August 1, 2012. Ms. Buck came to Libbey from Whirlpool Corporation (NYSE: WHR), which she joined in 1993 and where she most recently served as Chief Financial Officer, Global Product and Enterprise Cost Leadership, since October 2010. From 2009 to October 2010, Ms. Buck was Vice President, Finance - U.S., and from 2007 to the end of 2008 she served as Vice President, Cost Leadership. Previous roles with Whirlpool included Vice President, Finance - International and Corporate Vice President, Business Performance Management.
Sherry L. Buck ,于2012年8月1日加入Libbey,担任副总裁以及财务总监。她从Whirlpool 公司 (NYSE: WHR)转到了Libbey公司,她是于1993年加入Whirlpool并自2010年10月以来最近担任全球产品和企业成本管理首席执行官的。在2009-2010年10月以来,她曾是财务副总裁(美国),以及在2007-2008年末,她曾担任成本管理副总裁。他先前在Whirlpool的职位包括财务副总裁(国际)以及企业绩效管理副总裁。
Sherry L. Buck joined Libbey as Vice President, Chief Financial Officer on August 1, 2012. Ms. Buck came to Libbey from Whirlpool Corporation (NYSE: WHR), which she joined in 1993 and where she most recently served as Chief Financial Officer, Global Product and Enterprise Cost Leadership, since October 2010. From 2009 to October 2010, Ms. Buck was Vice President, Finance - U.S., and from 2007 to the end of 2008 she served as Vice President, Cost Leadership. Previous roles with Whirlpool included Vice President, Finance - International and Corporate Vice President, Business Performance Management.